Alzheimer's Disease Synthetic Biology Companies
Overview
Mermaid diagram (expand to render)
This category covers biotechnology and pharmaceutical companies developing synthetic biology approaches for Alzheimer's disease beyond traditional PROTACs and molecular glues. These companies leverage engineered biological systems including engineered proteins, engineered enzymes, gene circuits, metabolic engineering, biosensors, and cell engineering to develop novel disease-modifying therapies.
| Technology | Description | Application in AD |
|------------|-------------|------------------|
| Engineered Proteins | Modified therapeutic proteins with enhanced properties | Improved brain penetration, target specificity |
| Engineered Enzymes | Optimized enzymes for protein clearance | Amyloid-degrading enzymes, aggregation inhibitors |
| Gene Circuits | Synthetic genetic circuits for controlled expression | Regulated therapeutic protein production |
| Metabolic Engineering | Modified metabolic pathways for neuroprotection | Bioenergetic support, metabolite production |
| Biosensors | Engineered detection systems for biomarkers | Early diagnosis, treatment monitoring |
| Cell Engineering | Modified cells for therapeutic delivery | Engineered probiotics, cellular therapeutics |
Major Companies
Ginkgo Bioworks
Headquarters: Boston, Massachusetts
Founded: 2008
NASDAQ: DNA
Ginkgo Bioworks is a leading synthetic biology company with a platform for organism engineering that combines software, hardware, and biological innovation. Their foundry capabilities include automated strain design, enzyme engineering, biosensor development, and therapeutic protein production[@ginkgo].
Alzheimer's Disease Applications:
- Engineered cell lines for AD disease modeling
- Protein aggregation studies
- High-throughput drug screening platforms
- Biosensor development for biomarker detection
See Also: [Ginkgo Bioworks](https://www.ginkgobioworks.com)[@ginkgocompany]
Twist Bioscience
Headquarters: South San Francisco, California
Founded: 2013
NASDAQ: TWST
Twist Bioscience is a leading DNA synthesis company providing synthetic genes, gene fragments, and oligo pools for drug discovery and development[@twist].
Alzheimer's Disease Applications:
- Synthetic gene synthesis for AD research
- Custom antibody discovery platforms
- Epitope mapping for tau and amyloid antibodies
- Gene panel screening for target identification
See Also: [Twist Bioscience](https://www.twistbioscience.com)
Codexis
Headquarters: Redwood City, California
Founded: 2007
NASDAQ: CDXS
Codexis is an enzyme engineering company that develops and manufactures high-performance enzymes for pharmaceutical manufacturing and biotherapeutics[@codexis].
Alzheimer's Disease Applications:
- Engineered enzymes for therapeutic protein manufacturing
- Novel enzyme therapeutics for protein clearance
- Biocatalysis for drug synthesis
- Enzyme optimization for brain delivery
See Also: [Codexis](https://www.codexis.com)
Recursion Pharmaceuticals
Headquarters: Salt Lake City, Utah
Founded: 2013
NASDAQ: RXRX
Recursion Pharmaceuticals combines experimental biology and computational approaches to drug discovery using a high-throughput platform[@recursion].
Alzheimer's Disease Applications:
- Phenotypic screening using engineered cell models
- Machine learning for novel target identification
- Repurposing candidates for AD
- Understanding protein aggregation mechanisms
See Also: [Recursion Pharmaceuticals](https://www.recursion.com)
Arzeda
Headquarters: Seattle, Washington
Founded: 2008
Private
Arzeda uses computational protein design to create novel enzymes with improved catalytic properties and stability[@arzeda].
Alzheimer's Disease Applications:
- Engineered enzymes for amyloid clearance
- Novel therapeutic enzyme development
- Protein engineering for enhanced brain delivery
- Metabolite production for neuroprotection
See Also: [Arzeda](https://www.arzeda.com)
Molekule
Headquarters: San Francisco, California
Founded: 2014
Private
Molekule is focused on developing engineered enzyme therapeutics for precision degradation of disease-causing proteins[@molekule].
Alzheimer's Disease Applications:
- Engineered amyloid-degrading enzymes
- Tau aggregation inhibitors
- Protein clearance therapeutics
- Novel degradation platforms
See Also: [Molekule](https://www.molekule.com)
Emerging Companies
Engineered Protein Companies
| Company | Focus | Stage |
|---------|-------|-------|
| Molekule | Engineered amyloid-degrading enzymes | Preclinical |
| Codexis | Enzyme therapeutics | Preclinical |
| Arzeda | Computational enzyme design | Discovery |
Gene Circuit & Cell Engineering Companies
| Company | Focus | Stage |
|---------|-------|-------|
| Ginkgo Bioworks | Engineered cell therapies | Discovery |
| Recursion | Phenotypic screening platform | Phase 1/2 |
Biosensor Companies
| Company | Focus | Stage |
|---------|-------|-------|
| Ginkgo Bioworks | Biomarker biosensors | Discovery |
| Twist Bioscience | Diagnostic detection | Development |
Technology Comparison
| Company | Platform | Key Advantage | AD Focus |
|---------|----------|---------------|----------|
| Ginkgo Bioworks | Foundry automation | Scale, speed | Disease modeling, screening |
| Twist Bioscience | DNA synthesis | High-throughput | Antibody discovery |
| Codexis | Enzyme engineering | Catalytic efficiency | Protein clearance |
| Recursion | Phenotypic screening | Phenotypic insights | Target identification |
| Arzeda | Computational design | Novel enzymes | Enzyme therapeutics |
| Molekule | Precision degradation | Specificity | Protein clearance |
Therapeutic Approaches
Engineered Protein Therapeutics
Engineered proteins offer advantages over small molecules including:
- Higher target specificity
- Novel mechanisms of action
- Reduced off-target effects
- Enhanced brain penetration through engineering
Enzyme Therapeutics
Enzyme-based approaches for AD include:
- Amyloid-degrading enzymes (neprilysin, IDE)
- Aggregation inhibitors
- Metabolic enzymes for bioenergetic support
Cell Engineering
Cell-based therapies leverage:
- Engineered probiotics for gut-brain axis modulation
- Cellular factories for therapeutic protein production
- Immune cells engineered for CNS delivery
Related Pages
- [AD Targeted Protein Degradation Companies](/companies/ad-targeted-protein-degradation-companies)
- [AD Computational Drug Discovery](/companies/ad-computational-drug-discovery)
- [Synthetic Biology Mechanism](/mechanisms/synthetic-biology)